employed two distinct mouse models: a genetically engineered mouse model of CRC with either intact or disrupted biological clocks in intestinal epithelial cells, and a shift disruption mouse model with systemic clock disorders-to investigate how circadian rhythms interact with the tumour immune microenvironment. Here, CLOCK is linked to neoplasm.